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ABSTRACT
The prevalence of allergic diseases has increased all over the world during the last two decades. Dietary
change is considered to be one of the environmental factors that cause this increase and worsen allergic symp-
toms. If this is the case, an appropriate intake of foods or beverages with anti-allergic activities is expected to
prevent the onset of allergic diseases and ameliorate allergic symptoms. Flavonoids, ubiquitously present in
vegetables, fruits or teas possess anti-allergic activities. Flavonoids inhibit histamine release, synthesis of IL-4
and IL-13 and CD40 ligand expression by basophils. Analyses of structure-activity relationships of 45 flavones,
flavonols and their related compounds showed that luteolin, ayanin, apigenin and fisetin were the strongest in-
hibitors of IL-4 production with an IC50 value of 2―5 μM and determined a fundamental structure for the inhibi-
tory activity. The inhibitory activity of flavonoids on IL-4 and CD40 ligand expression was possibly mediated
through their inhibitory action on activation of nuclear factors of activated T cells and AP-1. Administration of
flavonoids into atopic dermatitis-prone mice showed a preventative and ameliorative effect. Recent epidemi-
ological studies reported that a low incidence of asthma was significantly observed in a population with a high
intake of flavonoids. Thus, this evidence will be helpful for the development of low molecular compounds for al-
lergic diseases and it is expected that a dietary menu including an appropriate intake of flavonoids may provide
a form of complementary and alternative medicine and a preventative strategy for allergic diseases. Clinical
studies to verify these points are now in progress.
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INTRODUCTION
The worldwide prevalence of allergic diseases such
as asthma, atopic dermatitis and allergic rhinitis has
increased during the last two decades1-3 and it is as-
sumed that in Japan more than one-third of the popu-
lation is now suffering from at least one of these dis-
eases. For instance, the first case of Japanese cedar
pollinosis was reported in the mid-1960s4 but now
half of the Japanese population has become sensi-
tized with Japanese cedar pollens and 24―29% of the
population is suffering from this disease.5 This trend
has led not only to a significant increase in patient
morbidity but also in cost to the patients and their
families and has placed a great burden on society.6-8
The interaction between genetic and environmental
factors is generally accepted to cause individuals to
be sensitized with environmental allergens and to suf-
fer from allergic diseases.9-12 However, it is believed
that recent changes in the environment have contrib-
uted to the increase more significantly than genetic
factors, since it seems unlikely that genes would
change over one or two generations. Thus, it is a cen-
tral issue to reveal what environmental factor(s)
cause such high prevalence and to find strategies to
prevent their development.11,13,14 Recently the
change of diet is considered to be one of the environ-
mental factors responsible for such an increase.15,16
Indeed, foods include both allergy-promoting and
anti-allergic nutrients. In this article we will propose
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the possibility that an appropriate intake of flavonoids
with anti-allergic activity may provide an effective
form of complementary and alternative medicine and
a preventative strategy for allergic diseases.
NUTRITION WITH ALLERGY PROMOTING
AND INHIBITING ACTIVITY
Changes in environmental factors may contribute to
the increase in the prevalence of allergic diseases. As
environmental factors that influence the susceptibility
to the development of asthma in predisposed indi-
viduals, the Global Strategy for Asthma Management
and Prevention lists indoor and outdoor allergens, oc-
cupational sensitizers, air pollution, respiratory infec-
tion, parasitic infections, socioeconomic status, family
size and obesity.11 The Asthma Prevention and Man-
agement Guideline 2006, Japan indicates allergens,
viral infection, in particular the RS virus, indoor and
outdoor air pollution, smoking, food and its additives,
parasite infection and drugs as triggering factors for
the onset of asthma.17 The hygiene hypothesis of al-
lergic diseases indicates that environmental changes
in the industrialized world have led to reduced micro-
bial contact at an early age and thus resulted in the
growing epidemic of allergic diseases.18-20 The condi-
tions of living, the development of anti-microbial
agents and vaccination, and small numbers of sib-
lings lead to decreased opportunities of infections in-
cluding mycobacterium tuberculosis or type A hepati-
tis virus, which are hypothesized to change T helper
(Th)1Th2 balance. Secondly, increased exposure to
allergens may contribute to the increase. Changes in
living conditions such as maintaining the indoors at
constant temperature and humidity levels also have
resulted in conditions that are optimal for house dust
mites to grow and there has been increased opportu-
nity for keeping pets at home. Thirdly, air pollution
including diesel particles, ozone and nitrogen oxide is
thought to be associated with the increase.
Recently it has been pointed out that dietary
change might contribute to the onset of allergic dis-
eases.16 Indeed, nutrients with anti-allergy and
allergy-promoting activities are included in foods and
beverages.15 Vitamins A, C, E, selenium and copper
are antioxidants and vitamin C and E also have other
anti-inflammatory and anti-allergic effects. Magne-
sium, when given intravenously, shows bronchodila-
tion effect and inhibits degranulation by mast cells.
Omega-3 polyunsaturated fatty acids (PUFA) stabilize
the mast cell membrane and decrease leukotriene C4
synthesis, whereas omega-6 PUFA are precursors for
leukotriene C4 and thus promote allergic inflamma-
tion. A high sodium intake may be associated with in-
creased airway responsiveness. Based on the activity
of the nutrients and the epidemiological studies, die-
tary manipulation of these nutrients may ameliorate
allergic symptoms. However, intervention studies so
far have reached no consistent conclusion. Devereux
et al. recently reported that reduced consumption of
foods containing antioxidants (fruits and vegetables),
increased omega-6 PUFA intake and reduced omega-
3 PUFA intake have been implicated for the increase
in asthma and atopic diseases and they pointed out
that dietary antioxidant and lipid intakes during preg-
nancy and early childhood might decrease the onset
of allergic diseases.16
Guidelines for prevention of asthma and allergic
diseases were recently proposed by the World Al-
lergy Organization, based on the results of numerous
clinical studies.21 As primary prevention, four points
were raised as follows. Firstly, maternal dietary re-
strictions during breastfeeding are not recom-
mended. Secondly, breastfeeding for at least the first
4―6 months is exclusively recommended. Thirdly,
maternal smoking and passive smoking of children
should be avoided. Fourthly, avoidance of exposure
to inhaled allergens is recommended for infants at
high risk for development of allergic diseases. The
reason why breastfeeding is beneficial to prevent the
onset of allergic diseases remains to be determined,
but factors including soluble IgA, soluble CD14,
transforming growth factor (TGF)-β, omega-3 PUFA
or others in breast milk are considered to play an in-
hibitory role.22 Therefore, to reveal what foods or
beverages are recommended during the pregnancy
and lactation period for mothers whose children are
at high risk for sensitization of allergens and develop-
ment of allergic diseases is an important issue. In-
deed, it was reported that administration of probiot-
ics, Lactobacillus GG, prenatally to mothers and post-
natally for 6 months to their infants, resulted in a fre-
quency of atopic eczema in children aged 2 years of
half that of the placebo group23 and this preventative
effect of probiotics on atopic eczema persisted at least
4 years.24 Moreover fish oil (omega-3 PUFA) supple-
mentation in pregnancy from the 20th week of gesta-
tion until delivery was shown to result in decreased
severity of dermatitis in children at 1 year of age al-
though there was no difference in the frequency of
atopic dermatitis in comparison with the placebo
group.25
FLAVONOIDS ARE CANDIDATE NUTRIENTS
FOR PREVENTION AND COMPLEMENTARY
AND ALTERNATIVE MEDICINE FOR ALLER-
GIC DISEASES
FLAVONOIDS INHIBIT INTERLEUKIN (IL)-4, IL-13
AND CD40 LIGAND EXPRESSION BY ACTI-
VATED BASOPHILS
Although there are many kinds of traditional reme-
dies for allergic diseases in the world, whether most
of such remedies are truly complementary or alterna-
tive medicine remains unknown and some of these
are now being tested.26 More than 10 years ago we
evaluated the clinical effect of one kind of traditional
vegetarian diet on adult patients with atopic dermati-
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Fig. 1 Structures of basic flavonoid skeletons
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tis.27 After a 2-month period of treatment, the severity
of dermatitis decreased from 49.9 ± 18.6 to 27.4 ± 16.8
based on a score of atopic dermatitis severity, the
SCORAD index and on serological parameters includ-
ing lactate dehydrogenase-5 activity and a number of
peripheral eosinophils. The amount of urinary secre-
tion of 8-hydroxy-2’-deoxyguanosine, a marker of oxi-
dative DNA damage, was also decreased.28 Since this
study was open and not placebo-controlled, what fac-
tor(s) led to decreased SCORAD scores remained un-
known. Subsequent studies showed that one of the
characteristics of this remedy was a high intake of fla-
vonoids. By this vegetarian diet, it was calculated that
17 mg of apigenin, 1.6 mg of luteolin, 19.5 mg of
quercetin, and 29 mg of kaempferol were consumed
daily. Thus, we focused our attention on the biologi-
cal activities of flavonoids.
Flavonoids are comprised of a large group of low
molecular weight polyphenolic secondary plant me-
tabolites and are found in fruits, vegetables, nuts,
seeds, stems, flowers, roots, bark, tea, wine and cof-
fee and are thus common substances in our daily
diet.29,30 Flavonoids have been recognized to exert
antioxidant, anti-bacterial and anti-viral activity, and
possess anti-inflammatory, anti-angionic, analgesic,
hepatoprotective, cytostatic, apoptotic, estrogenic or
anti-estrogenic properties as well as anti-allergic ef-
fects.31,32 Based on their skeleton, flavonoids are cate-
gorized into eight groups: flavans, flavanones,
isoflavanones, flavones, isoflavones, anthocyanidins,
chalcones and flavonolignans (Fig. 1). Their skeleton
is a heterocyclic hydrocarbon, chromane, and substi-
tution of its ring C in position 2 or 3 with a phenyl
group (ring B) results in flavans or isoflavans. An
oxo-group in position 4 leads to flavanones and
isoflavanones. The presence of a double bond be-
tween C2 and C3 provides flavones and isoflavones.
An additional double bond in between C1 and C2
makes these compounds colorful anthocyanidins.
Natural flavonoids usually occur as glycosides (e.g.
glucosides, rhamnoglucosides, and rutinosides) and
more that 8,000 different flavonoids have been identi-
fied.31,32
Mast cells and basophils expressing high affinity
IgE receptor (FcεRI) play an important role in aller-
gic inflammation through releasing chemical media-
tors such as histamine and cysteinyl leukotrienes, cy-
tokines and chemokines.33-36 Fewtress and Gomperts
first demonstrated the anti-allergic effect of flavone in-
hibition of transport ATPase in histamine secretion
from rat mast cells.37 Quercetin inhibition of allergen-
stimulated human basophils was reported subse-
quently.38,39 Similarly, Cheong et al. showed the
structure activity relationship of flavonoids for anti-
allergic actions through analyses of their inhibitory
activity on hexosaminidase release from rat mast
cells. Apigenin, luteolin, 3.6-dihydroxy flavones,
fisetin, kaempferol, quercetin, and myricetin were
found to inhibit such release with an IC50 value of
less than 10 μM.40 Flavonoids have also been shown
to suppress cysteinyl leukotriene synthesis through
an inhibition of phospholipase (PL) A2 andor 5-
lipoxygenase (5LO). Quercetin was first demon-
strated to be an inhibitor of PLA241 and later it was re-
ported that quercetagetin, kaempferol-3-O-
galactoside, and scutellarein also possessed this activ-
ity with IC50 values ranging from 12.2 to 17.6 μM.42 A
number of flavonoids possess 5LO inhibitory activity.
For instance, cirsiliol ( 3 ’, 4 ’, 5-trihydroxy-6,7-
dimethoxy flavone) caused 97% inhibition of 5LO ac-
tivity from rat basophilic cells and 99% suppression of
release of cysteinyl leukotrienes from guinea pig
lung.43 Kimata et al. reported that luteolin, quercetin
and baicalein inhibited not only the release of hista-
mine, leukotrienes and prostaglandin D2 but also the
secretion of granulocyte macrophage-colony stimulat-
ing factor by human cultured mast cells in response
to cross-linkage of FcεRI44 and subsequently showed
that these compounds also inhibited IgE-mediated tu-
mor necrosis factor (TNF)-α and IL-6 production by
bone marrow-derived cultured murine mast cells.45
Thus these reports indicate that flavonoids are inhibi-
tors of chemical mediator release and cytokine pro-
duction by mast cells.
One of the characteristic features of allergic dis-
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eases is overproduction of IgE to environmental aller-
gens. For the differentiation of B cells into IgE pro-
ducing cells, both the interaction of CD40 ligand with
CD40 and the action of IL-4 or IL-13 on B cells are re-
quired.46 The cells which are able to send these sig-
nals to B cells are reportedly Th2 cells, basophils and
mast cells.47 Thus, the effect of flavonoids on IL-4, IL-
13 and CD40 ligand expression was examined by ba-
sophils. Purified peripheral blood basophils or a hu-
man basophilic cell line, KU812, were stimulated with
anti-IgE antibody or PMA+A23187, respectively, in
the presence or absence of various concentrations of
flavonoids. In KU812 cells, fisetin suppressed IL-4, IL-
5 and IL-13 production but the suppressive effect of
fisetin on IL-6, IL-8 and IL-1β was relatively weak.48
Luteolin, apigenin and fisetin strongly suppressed
both IL-4 and IL-13 synthesis by allergen or anti-IgE
antibody-stimulated peripheral blood basophils and
the IC50 value of these flavonoids for inhibition of IL-
4 synthesis was 2―6 μM.49,50 These flavonoids also in-
hibit IL-4 production by anti-CD3 antibody-stimulated
T cells but the required concentration was higher
(IC50 = 10―19 μM). Similarly, Matsuda et al reported
that apigenin, luteolin and fisetin inhibited IL-4 and
TNF-α synthesis in rat mast cell line, RBL-2H3
cells.51 In addition, luteolin, apigenin and fisetin in a
dose-dependent manner suppressed CD40 ligand ex-
pression by PMA+A23187-stimulated basophils and
KU812 cells, whereas myricetin even at 30 μM did
not possess such activity.52 These inhibitory activities
of luteolin on the expression of IL-4, IL-13 and CD40
ligand were accompanied with its suppressive activity
of mRNA expression of IL-4, IL-13 and CD40 ligand.
Therefore, flavonoids such as luteolin, apigenin and
fisetin are considered as potential natural IgE inhibi-
tors.
HIERARCHY OF FLAVONOIDS AND RELATED
COMPOUNDS IN THE INHIBITORY ACTIVITY ON
IL-4 SYNTHESIS BY BASOPHILS
In order to determine the basic structure of fla-
vonoids for the inhibition of IL-4 production and
search for more active compounds, 45 kinds of fla-
vones, flavonols and their related compounds were
then screened. Purified basophils were pre-incubated
with various concentrations of flavonoids (1 to 30
μM), and then stimulated with anti-IgE antibody and
IL-3 for 12 hours. IL-4 in the supernatant was meas-
ured by means of ELISA and the inhibitory activity of
each compound was shown as an IC50 value (Fig. 2).
Ayanin, luteolin, apigenin, and compound 31 are the
strongest inhibitors with an IC50 value of 2.2―3.2 μM.
Next, diosmetin, fisetin, ombuin and compound 5
showed an inhibitory activity with an IC50 value of
5.2―6.5 μM. Compound 11, in which carbon is ex-
changed for nitrogen in position 4’ in the B ring, pos-
sesses an inhibitory activity with an IC50 value of 4.8
μM, while compound 10, in which carbon is replaced
for nitrogen in the position 6’, does not have such ac-
tivity. Quercetin and kaempferol are representative
flavonoids consumed substantially daily and have an
intermediate activity of inhibition for IL-4 synthesis
with an IC50 value of 15.7―18.8 μM. However,
myricetin lacks such activity. These analyses of
structure-activity relationship revealed the fundamen-
tal structure for the activity. For maximal inhibition,
hydroxylation in positions 7 and 4’ is essential and ad-
ditionally the presence of OH in either position 3 or 5
is required. The glycosylation of position 3 decreases
the activity.
MECHANISMS THROUGH WHICH FLAVONOIDS
INHIBIT IL-4, IL-13 AND CD40 LIGAND EXPRES-
SION BY BASOPHILS
Signaling pathways through FcεRI in mast cells33,53
and basophils54 were reviewed. In basophils, cross-
linking of FcεRI induces activation of various tyrosine
kinases including Lyn and Syk, which lead to the
stimulation of phosphatidylinositol 3 (PI3)-kinases,
mitogen-activated protein kinases (MAPK) and PLC.
The PI3-kinases then activate RacRho GTPases and
p38 MAPK, which are involved in the production of
cytokines such as IL-4 and IL-13. RacRho GTPases
also affect the cytoskeletal processes during degranu-
lation as well as P4442 MAPK. P4442 MAPK activa-
tion is reported to lead to the synthesis of cysteinyl
leukotrienes, while protein kinase C (PKC) activated
by diacylglycerol is involved in degranulation and
may also affect cytokine transcription. The release of
calcium by IP3 affects degranulation, PLA2 transloca-
tion and calcineurin activity. Thus, several signaling
molecules are associated with induction of IL-4 tran-
scription. While the precise mechanism for CD40
ligand expression in basophils remains unknown, it
was found that in T cells, an increase in intracellular
calcium is an essential signal for its expression.55 The
stimulation of T cells with PMA stimulates activating
protein 1 (AP-1) through c-Jun N-terminal kinase
(JNK) and P4442 MAPK activation and synergisti-
cally enhances CD40 ligand transcription with the nu-
clear factor of activated T cells (NFAT).56
Then, in order to reveal acting points of flavonoids
in basophils, whether or not flavonoids might inhibit
activation of several signaling molecules was asked.
The effect of luteolin or fisetin as an active reagent or
the effect of myricetin as an inactive reagent on the
activation of Syk or Lyn by anti-IgE antibody+IL-3-
stimulated basophils or on the activation of MAPK
family including P38 MAPK, P4442 MAPK, P5446
SAPKJNK and on the activation of transcriptional
factor including NFAT and AP-1 by A23187+PMA-
stimulated KU812 cells was examined. Luteolin failed
to inhibit Syk, Lyn and MAPK family activation
whereas it inhibited both AP-1 and NFAT activa-
tion.49,50 However, myricetin did not inhibit AP-1 and
NFAT activation by KU812 cells. Thus, in our analy-
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Fig. 2 Hierarchy of inhibitory activity of 45 flavonoids and related compounds on IL-4 production by basophils Purified baso-
phils were pre-incubated with various concentrations of flavonoid or related compound for 15 minutes, and stimulated with anti-
IgE antibody plus IL-3 for 12 hours. The concentration of IL-4 in the supernatant was measured. The inhibitory activity of each 
compound is shown as an average of IC50 values.
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ses the inhibitory activity of flavonoids on IL-4, IL-13
and CD40 ligand expression is considered to be me-
diated by their suppressive action on these transcrip-
tional factors. Park et al. recently reported that api-
genin inhibits IL-4 production by mouse T cells via
down-regulation of NFAT DNA binding activity.57
How flavonoids inhibit AP-1 and NFAT activation
awaits clarification, but it has been demonstrated that
nitric oxide also inhibits IgE-dependent cytokine pro-
duction and FosJun activation and NFAT without in-
hibition of MAPK family in RBL-2H3 mast cells,58 so
that the actions of flavonoids resemble those of nitric
oxide.
In previous studies regarding the action of fla-
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vonoids on basophils or mast cells, several findings
have been reported. Kimata et al. showed that luteo-
lin and quercetin inhibited Ca2+ influx, PKC activity,
p4442 MAPK and JNK activation but not p38 MAPK
by human cultured mast cells in response to cross-
linkage of FcεRI.44 Shichijo et al. demonstrated that
flavonoids inhibited Syk activation, also in human cul-
tured mast cells in response to cross-linkage of
FcεRI.59 However, the relationship between the inhi-
bition of Syk activation and degranulation was un-
clear, since myricetin proved to be a strong inhibitor
of Syk activation but a week suppressor of degranula-
tion. In another study, flavones including apigenin
were found to reduce the FcεRI α and γ chains, per-
haps through down-regulating P4442 MAPK phos-
phorylation in KU812 cells.60 The reasons for this dis-
crepancy between our results and previously re-
ported findings that flavonoids inhibited MAPK fam-
ily members are not known at the present time but it
may be due to differences in cells, stimulation, doses
of flavonoids or it may be due to the presence of sev-
eral acting points of flavonoids. Further studies are
required to clarify these points.
CLINICAL EFFECTS OF FLAVONOIDS
Based on the anti-allergic activity, whether intake of
flavonoids might be effective for the amelioration of
allergic symptoms or for prevention of the onset of al-
lergic diseases was tested. NCNga mouse spontane-
ously develops severe eczema, scratching behaviour
and serum IgE elevation with aging under nonspe-
cific pathogen free circumstances.61 To see the pre-
ventative effect, the mice were orally given astragalin,
kaempferol 3’glucoside (1.5 mgkg) or a control
diet.62 Development of dermatitis was observed in the
control group with aging and the severity of dermati-
tis was evaluated by scoring. Oral intake of astragalin
remarkably inhibited the appearance of the skin
symptoms, scratching behaviour and serum IgE ele-
vation. Moreover, astragalin significantly diminished
the severity of dermatitis, scratching behaviour and
transepidermal water loss even after onset.63 Simi-
larly, by using this model mouse, it has been subse-
quently shown that administration of extract from pet-
als of Impatiens balsamina L. including flavonoids
such as kaempferol 3-rutinoside and 2-hydroxy-1,4-
naphthoquinone as active gradients suppressed
scratching behaviour and dermatitis.64 Moreover, in
an asthmatic model mouse sensitized with ovalbu-
min, it was demonstrated that oral administration of
luteolin, even at a dose of 0.1 mgkg, led to a signifi-
cant suppression of bronchial hyperreactivity and
bronchoconstriction.65 Nobiletin, a polymethoxyfla-
vonoid, when given at a dose of 1.5 or 5 mgkg in-
traperitoneally into OVA-sensitized rats, was recently
reported to reduce OVA-induced increases in eosino-
phils and eotaxin expression.66 Substances, used in
traditional remedies for allergic diseases are found to
include flavonoids. For instance, Perilla frutescens
BRITTON, a medicinal herb prescribed in Saiboku-to
contains luteolin glucoside, apigenin glucoside,
scutellarin and rosmarinic acid and oral administra-
tion of Perilla frutescens inhibits PCA reaction in
mice.67 Isoquercitrin from Argemone platyceras, tradi-
tionally used for cough, bronchitis and pneumonia in
Mexico, inhibits carbachol and leukotriene D4-
induced contraction in guinea-pig airways.68 Also, ex-
tract of flowers of Impatiens textori MIQ containing
apigenin, apigenin 7-glucoside and luteolin is shown
to inhibit antigen-induced anaphylaxis in ddY mice.69
Thus these reports raise the possibility that the active
gradients used in some traditional remedies for aller-
gic diseases are flavonoids.
We attempted to examine the clinical effect of per-
simmon leaf extract on adult patients with atopic der-
matitis in randomized controlled trials (Takigawa et
al. unpublished data), since persimmon leaf extract
tea included 0.45―0.72% astragalin, 0.38―0.55% iso-
quercitrin (quercetin 3-glycoside) and 0.32% to-
riphorin (kaempferol 3-galactoside). Patients were
treated with placebo, or 1 g or 2 g of persimmon leaf
extract for 4 weeks without any change in medica-
tion, and the severity of their skin lesions was meas-
ured according to the SCORAD index. The intake of
persimmon leaf extract at a dose of 1 g and 2 gday
significantly decreased the SCORAD index, which
was accompanied by a decrease in the number of pe-
ripheral blood eosinophils. In order to verify that fla-
vonoid is effective in patients with atopic dermatitis,
further studies involving a large number of partici-
pants are required, but these preliminary data, we be-
lieve, seem to be promising as complementary and al-
ternative medicine for atopic dermatitis.
Enzymatically modified isoquercitrin is a quercetin
glycoside that consists of isoquercitrin and its maltoo-
ligosaccharides, and it is manufactured from rutin
through enzymatic modification.70 By this modifica-
tion, the absorption rate through the intestine was re-
markably increased. This flavonoid is recognized as a
food additive in the List of Existing Food Additives
(Notification No. 120, Japanese Ministry of Health
and Welfare, April 16, 1996)71 and is commonly used
for various foods such as beverages etc. as an anti-
oxidant which has high solubility in water. Therefore,
whether or not intake of enzymatically modified iso-
quercitrin is effective for allergic diseases is now be-
ing tested.
EPIDEMIOLOGICAL REPORTS REGARDING
THE ASSOCIATION OF INTAKE OF FLA-
VONOIDS WITH ALLERGIC DISEASES
Is it evident that an excess (or appropriate) intake of
flavonoids contributes to decrease the prevalence of
allergic diseases or ameliorate allergic symp-
toms?72,73 So far, epidemiological evidence does not
appear to lead to a definitive conclusion that fla-
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vonoids have in vivo beneficial effects in allergic dis-
eases. Two studies have suggested that a high intake
of fresh fruit74 and vegetables75 may protect against
asthma, but neither could determine which specific
foods or nutrients were responsible. Subsequently
Shaheen et al. reported that in a population-based
case-control study in South London, apple consump-
tion or red wine intake were negatively associated
with asthma prevalence or severity, respectively, per-
haps due to a protective effect of flavonoids.76 More-
over, a 30-year longitudinal epidemiological study re-
ported that the incidence of asthma is lower in popu-
lations with higher intake of flavonoids and that the
relative risk was 0.6577 whereas in a population-
based, case-control study of 1471 adults in London,
dietary intake of three flavonoid subclasses (cate-
chins, flavonols and flavones) is reported not to be as-
sociated with asthma.78 Since in the past studies the
amount of daily intake of flavonoids was estimated by
questionnaire and was the total amount of three ma-
jor flavonoids including quercetin, kaempferol and
myricetin, more precise analysis of flavonoid intake in
quantity and quality will be required to lead to a con-
clusion.
IS AN APPROPRIATE INTAKE OF FLA-
VONOIDS EFFECTIVE AS A FORM OF COM-
PLEMENTARY OR ALTERNATIVE MEDICINE
FOR THE TREATMENT OR PREVENTION OF
ALLERGIC DISEASES?
The findings regarding in vitro or in vivo anti-allergic
properties of flavonoids are summarized (Table 1).
Flavonoids, particular luteolin, apigenin and fisetin
have strong anti-allergic activities such as inhibition
of histamine release, of IL-4 and IL-13 synthesis and
of CD40 ligand expression by basophils and perhaps
mast cells. The inhibitory activity of flavonoids on IL-
4, IL-13 and CD40 ligand expression may be medi-
ated through their inhibition of transcriptional factors
such as AP-1 and NFAT. In some allergic model
mice, oral administration of flavonoids has been
shown effective as treatment or prevention. One lon-
gitudinal epidemiological study supports this idea.
On the basis of this evidence, as future studies, we
consider the following points (Fig. 3). Firstly, novel
anti-allergic drugs, which suppress IgE production
and allergic inflammation through their inhibitory ac-
tivity of IL-4 and IL-13 synthesis and of CD40 ligand
expression by basophils and mast cells, will be devel-
oped. Further modifications of structure may lead to
higher active compounds. The glycosylation may
make flavonoids more soluble and absorptive
through the small intestine if oral administration is
considered. Secondly, it is essential to test whether
an appropriate intake of flavonoids is truly effective
for the prevention or dietary treatment of allergic dis-
eases through well-controlled study. Thirdly, more
epidemiological analyses regarding the association of
flavonoid intake in quantity and in quality with preva-
lence or severity of allergic diseases will be required.
Flavonoids are included in plant foods and bever-
ages, and people consume substantial amounts of fla-
vonoids.29,30 The daily intake of flavonoids, calculated
by the amounts of quercetin, kaempferol and
myricetin, in some reports, plus luteolin, apigenin
and fisetin, has been reported in several countries.73
The total amount of flavonoids varied from 2.6 to 68.2
mgday in European countries, USA and Japan. In
each country the major flavonoid was quercetin, rang-
ing from 14 to 100% of the total amount of flavonoids,
followed by kaempferol and myricetin with an aver-
age intake of 0.1 to 5.9 mgday. Luteolin, apigenin
and fisetin, strong inhibitors of IL-4 production, were
shown to be ingested but in average amounts of less
than 1 mgday. However, our recent analyses re-
vealed that in Japan middle-aged women consume
daily 5.6 mg of luteolin and 1.4 mg of apigenin and
vegetarian women take 1.6 mg of luteolin and 17 mg
of apigenin.
Regarding flavonoid content in foods and bever-
ages, a database of the content of the major fla-
vonoids in foods and beverages, including luteolin,
apigenin, quercetin and kaempferol, has recently
been established in the USA.79 Quercetin levels in the
edible parts of most vegetables are less than 10 mg
kg, except for onion (185―634 mgkg), kale (110―120
mgkg), broccoli (10―68 mgkg), and lettuce (5―30
mgkg). Quercetin is also included in apple (5―72
mgkg), orange (18 mgkg) and Japanese tea (12―90
mgl). Kaempferol could only be detected in kale
(211―470 mgkg), endive (15―91 mgkg), leek (11―
56 mgkg), broccoli (16―100 mgkg), parsley (11―45
mgkg), strawberry (8―19 mgkg) and orange (32
mgkg). Celery includes luteolin (22―200 mgkg)
and apigenin (17―750 mgkg), both of which showed
strong inhibitory activity on Th2 cytokine and CD40
ligand expression by basophils. Parsley also pos-
sesses apigenin (1850 mgkg) and luteolin (<1―11
mgkg). Fisetin is reported to be included in onion (5
mgkg), apple (27 mgkg) and strawberry (160 mg
kg). Thus, the data of flavonoid content in foods and
beverages and the hierarchy of flavonoid activity lead
to the concept that it is preferable for persons to take
flavonoids from what they like on the basis of their
quality and quantity. It should be pointed out, how-
ever, that the establishment in in vitro experiments of
a hierarchy of the inhibitory action of flavonoids does
not simply mean that an increase in the intake of fla-
vonoids with higher activity should be recommended,
since glycosylation of flavonoids usually increases the
absorption from the small intestine but decreases
their inhibitory activity on IL-4 synthesis.80 Therefore
progress in research regarding the bioavailability of
flavonoids will be essential for establishment of die-
tary management for allergic or other diseases.80,81
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Table 1 Summary of anti-alergic properties of flavonoids
1. Biological activities
Inhibition of histamine, Th2 cytokines (IL-4 and IL-13) and CD40 ligand expression in basophils and mast cels
2. Presumable mechanisms
Inhibition of activation of transcriptional factors such as AP-1 and NFAT
3. Hierarchy of inhibitory activity of representative flavonoids
Luteolin, apigenin, fisetin＞kaempferol, quercetin＞myricetin and others
4. Clinical efect
Preventative and ameliorative efect on dermatitis in NC/Nga mice
Ameliorative efect on dermatitis in adult patients with atopic dermatitis
5. Epidemiological report
The higher the intake of flavonoids, the lower the incidence of asthma (relative risk＝0.65）
Fig. 3 Future studies are required for flavonoids or related compounds 
to be novel anti-alergic drugs or to be used in the dietary menu for treat-
ment or prevention of alergic diseases.
8
Future studies
Epidemiological study; 
Association of flavonoid
intake with prevalence
and severity of allergic
diseases
Development of low molecular weight inhibitors
of IL-4, IL-13 and CD40 ligand expression
(Each OH for 3 or 5 position)
Development of dietary menu for
prevention or complementary and
alternative medicine for allergic diseases
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CONCLUSIONS
Allergy, one of the common diseases throughout the
world, is of growing concern because of its increasing
rate of prevalence. Dietary change may contribute to
this increase. Flavonoids, in particular luteolin, api-
genin and fisetin, possess anti-allergic activities that
inhibit histamine, IL-4, IL-13 and CD40 ligand expres-
sion by basophils and mast cells. The structure activ-
ity relationship of flavonoids and related compounds
determines the fundamental structure for inhibitory
activity of IL-4 synthesis and will be helpful for devel-
opment of new anti-allergy drugs through modifica-
tion. Since a database of the flavonoid content in ma-
jor vegetables, fruits and beverages has been devel-
oped, an appropriate intake of flavonoids from foods
and beverages is anticipated to ameliorate allergic
symptoms and prevent the onset of allergic diseases.
To achieve this goal, information regarding the
bioavailability of flavonoids and clinical trails to verify
the effectiveness will be required.
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